Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 05, 2024

SELL
$23.64 - $30.27 $1.02 Million - $1.31 Million
-43,211 Reduced 60.17%
28,599 $826,000
Q3 2023

Nov 06, 2023

BUY
$26.74 - $40.81 $457,334 - $697,973
17,103 Added 31.26%
71,810 $1.92 Million
Q2 2023

Jul 27, 2023

SELL
$28.52 - $40.7 $24,783 - $35,368
-869 Reduced 1.56%
54,707 $2.03 Million
Q1 2023

May 02, 2023

SELL
$29.39 - $36.27 $577,689 - $712,923
-19,656 Reduced 26.13%
55,576 $1.74 Million
Q4 2022

Feb 10, 2023

BUY
$29.23 - $40.28 $64,481 - $88,857
2,206 Added 3.02%
75,232 $2.24 Million
Q4 2022

Feb 09, 2023

BUY
$29.23 - $40.28 $1.31 Million - $1.8 Million
44,762 Added 158.37%
73,026 $2.17 Million
Q3 2022

Nov 02, 2022

BUY
$37.92 - $63.74 $28,440 - $47,805
750 Added 2.73%
28,264 $1.08 Million
Q2 2022

Aug 01, 2022

BUY
$47.98 - $62.75 $225,170 - $294,485
4,693 Added 20.56%
27,514 $1.5 Million
Q1 2022

May 04, 2022

BUY
$49.85 - $96.11 $239,280 - $461,328
4,800 Added 26.64%
22,821 $1.26 Million
Q4 2021

Feb 07, 2022

BUY
$77.3 - $105.0 $604,563 - $821,205
7,821 Added 76.68%
18,021 $1.81 Million
Q3 2021

Nov 02, 2021

BUY
$74.87 - $110.87 $117,620 - $174,176
1,571 Added 18.21%
10,200 $917,000
Q2 2021

Aug 03, 2021

SELL
$66.8 - $100.45 $151,435 - $227,720
-2,267 Reduced 20.81%
8,629 $796,000
Q1 2021

May 04, 2021

SELL
$59.3 - $183.85 $1.62 Million - $5.03 Million
-27,335 Reduced 71.5%
10,896 $1.05 Million
Q4 2020

Feb 01, 2021

BUY
$31.01 - $52.1 $1.19 Million - $1.99 Million
38,231 New
38,231 $1.99 Million
Q2 2020

Aug 07, 2020

SELL
$8.89 - $18.28 $14,250 - $29,302
-1,603 Closed
0 $0
Q1 2020

May 04, 2020

SELL
$6.75 - $19.75 $249 - $730
-37 Reduced 2.26%
1,603 $17,000
Q4 2019

Feb 04, 2020

BUY
$9.29 - $15.82 $4,199 - $7,150
452 Added 38.05%
1,640 $22,000
Q3 2019

Nov 12, 2019

BUY
$5.96 - $12.81 $7,080 - $15,218
1,188 New
1,188 $12,000

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $609M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.